Stonebridge Financial Group, LLC/CA’s Gilead Sciences GILD Stock Holding History

Stonebridge Financial Group, LLC/CA’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Buy	+1,800	New	+$237K	0.03%	271

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stonebridge Financial Group, LLC/CA's GILD Position: Q2 2026 in Review

Stonebridge Financial Group, LLC/CA opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,800 shares worth $227K. The stake represents 0.03% of the portfolio and ranks #271 among its holdings.

1,917 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Stonebridge Financial Group, LLC/CA held 1,800 shares of Gilead Sciences worth $227K as of Q2 2026.
Gilead Sciences was a new Stonebridge Financial Group, LLC/CA position in Q2 2026.
Gilead Sciences made up 0.03% of Stonebridge Financial Group, LLC/CA's portfolio in Q2 2026, its #271 holding.
1,917 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Stonebridge Financial Group, LLC/CA's 13F filing for Q2 2026, filed 13 Aug 2026.